0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Crizotinib Capsules Market Research Report 2026
Published Date: 2026-03-12
|
Report Code: QYRE-Auto-9C18046
Home | Market Reports
Global Crizotinib Capsules Market Research Report 2024
BUY CHAPTERS

Global Crizotinib Capsules Market Research Report 2026

Code: QYRE-Auto-9C18046
Report
2026-03-12
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Crizotinib Capsules Market

The global Crizotinib Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Crizotinib Capsules competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Crizotinib Capsules is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Crizotinib Capsules is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Crizotinib Capsules include Pfizer, Qilu Pharmaceutical, Jiangsu Hengrui Medicine, Chia Tai Tianqing Pharmaceutical Group, Cipla Limited, Glenmark Pharmaceuticals, Natco Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Crizotinib Capsules market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Crizotinib Capsules. The Crizotinib Capsules market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Crizotinib Capsules market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Crizotinib Capsules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Crizotinib Capsules Market Report

Report Metric Details
Report Name Crizotinib Capsules Market
Segment by Type
  • 200mg
  • 250mg
by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Qilu Pharmaceutical, Jiangsu Hengrui Medicine, Chia Tai Tianqing Pharmaceutical Group, Cipla Limited, Glenmark Pharmaceuticals, Natco Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Crizotinib Capsules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Crizotinib Capsules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Crizotinib Capsules Market report?

Ans: The main players in the Crizotinib Capsules Market are Pfizer, Qilu Pharmaceutical, Jiangsu Hengrui Medicine, Chia Tai Tianqing Pharmaceutical Group, Cipla Limited, Glenmark Pharmaceuticals, Natco Pharma

What are the Application segmentation covered in the Crizotinib Capsules Market report?

Ans: The Applications covered in the Crizotinib Capsules Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Crizotinib Capsules Market report?

Ans: The Types covered in the Crizotinib Capsules Market report are 200mg, 250mg

1 Crizotinib Capsules Market Overview
1.1 Product Definition
1.2 Crizotinib Capsules by Type
1.2.1 Global Crizotinib Capsules Market Value by Type: 2025 vs 2032
1.2.2 200mg
1.2.3 250mg
1.3 Crizotinib Capsules by Application
1.3.1 Global Crizotinib Capsules Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Crizotinib Capsules Market Size Estimates and Forecasts
1.4.1 Global Crizotinib Capsules Revenue 2021–2032
1.4.2 Global Crizotinib Capsules Sales 2021–2032
1.4.3 Global Crizotinib Capsules Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Crizotinib Capsules Market Competition by Manufacturers
2.1 Global Crizotinib Capsules Sales Market Share by Manufacturers (2021–2026)
2.2 Global Crizotinib Capsules Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Crizotinib Capsules Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Crizotinib Capsules, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Crizotinib Capsules, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Crizotinib Capsules, Product Types and Applications
2.7 Global Key Manufacturers of Crizotinib Capsules, Date of Entry into the Industry
2.8 Global Crizotinib Capsules Market Competitive Situation and Trends
2.8.1 Global Crizotinib Capsules Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Crizotinib Capsules Players Market Share by Revenue
2.8.3 Global Crizotinib Capsules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Crizotinib Capsules Market Scenario by Region
3.1 Global Crizotinib Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Crizotinib Capsules Sales by Region: 2021–2032
3.2.1 Global Crizotinib Capsules Sales by Region: 2021–2026
3.2.2 Global Crizotinib Capsules Sales by Region: 2027–2032
3.3 Global Crizotinib Capsules Revenue by Region: 2021–2032
3.3.1 Global Crizotinib Capsules Revenue by Region: 2021–2026
3.3.2 Global Crizotinib Capsules Revenue by Region: 2027–2032
3.4 North America Crizotinib Capsules Market Facts & Figures by Country
3.4.1 North America Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Crizotinib Capsules Sales by Country (2021–2032)
3.4.3 North America Crizotinib Capsules Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Crizotinib Capsules Market Facts & Figures by Country
3.5.1 Europe Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Crizotinib Capsules Sales by Country (2021–2032)
3.5.3 Europe Crizotinib Capsules Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Crizotinib Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Crizotinib Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Crizotinib Capsules Sales by Region (2021–2032)
3.6.3 Asia Pacific Crizotinib Capsules Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Crizotinib Capsules Market Facts & Figures by Country
3.7.1 Latin America Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Crizotinib Capsules Sales by Country (2021–2032)
3.7.3 Latin America Crizotinib Capsules Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Crizotinib Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Crizotinib Capsules Sales by Country (2021–2032)
3.8.3 Middle East and Africa Crizotinib Capsules Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Crizotinib Capsules Sales by Type (2021–2032)
4.1.1 Global Crizotinib Capsules Sales by Type (2021–2026)
4.1.2 Global Crizotinib Capsules Sales by Type (2027–2032)
4.1.3 Global Crizotinib Capsules Sales Market Share by Type (2021–2032)
4.2 Global Crizotinib Capsules Revenue by Type (2021–2032)
4.2.1 Global Crizotinib Capsules Revenue by Type (2021–2026)
4.2.2 Global Crizotinib Capsules Revenue by Type (2027–2032)
4.2.3 Global Crizotinib Capsules Revenue Market Share by Type (2021–2032)
4.3 Global Crizotinib Capsules Price by Type (2021–2032)
5 Segment by Application
5.1 Global Crizotinib Capsules Sales by Application (2021–2032)
5.1.1 Global Crizotinib Capsules Sales by Application (2021–2026)
5.1.2 Global Crizotinib Capsules Sales by Application (2027–2032)
5.1.3 Global Crizotinib Capsules Sales Market Share by Application (2021–2032)
5.2 Global Crizotinib Capsules Revenue by Application (2021–2032)
5.2.1 Global Crizotinib Capsules Revenue by Application (2021–2026)
5.2.2 Global Crizotinib Capsules Revenue by Application (2027–2032)
5.2.3 Global Crizotinib Capsules Revenue Market Share by Application (2021–2032)
5.3 Global Crizotinib Capsules Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Crizotinib Capsules Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Qilu Pharmaceutical
6.2.1 Qilu Pharmaceutical Company Information
6.2.2 Qilu Pharmaceutical Description and Business Overview
6.2.3 Qilu Pharmaceutical Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Qilu Pharmaceutical Crizotinib Capsules Product Portfolio
6.2.5 Qilu Pharmaceutical Recent Developments/Updates
6.3 Jiangsu Hengrui Medicine
6.3.1 Jiangsu Hengrui Medicine Company Information
6.3.2 Jiangsu Hengrui Medicine Description and Business Overview
6.3.3 Jiangsu Hengrui Medicine Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jiangsu Hengrui Medicine Crizotinib Capsules Product Portfolio
6.3.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.4 Chia Tai Tianqing Pharmaceutical Group
6.4.1 Chia Tai Tianqing Pharmaceutical Group Company Information
6.4.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
6.4.3 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product Portfolio
6.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
6.5 Cipla Limited
6.5.1 Cipla Limited Company Information
6.5.2 Cipla Limited Description and Business Overview
6.5.3 Cipla Limited Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Limited Crizotinib Capsules Product Portfolio
6.5.5 Cipla Limited Recent Developments/Updates
6.6 Glenmark Pharmaceuticals
6.6.1 Glenmark Pharmaceuticals Company Information
6.6.2 Glenmark Pharmaceuticals Description and Business Overview
6.6.3 Glenmark Pharmaceuticals Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Glenmark Pharmaceuticals Crizotinib Capsules Product Portfolio
6.6.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.7 Natco Pharma
6.7.1 Natco Pharma Company Information
6.7.2 Natco Pharma Description and Business Overview
6.7.3 Natco Pharma Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Natco Pharma Crizotinib Capsules Product Portfolio
6.7.5 Natco Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Crizotinib Capsules Industry Chain Analysis
7.2 Crizotinib Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Crizotinib Capsules Production Mode & Process Analysis
7.4 Crizotinib Capsules Sales and Marketing
7.4.1 Crizotinib Capsules Sales Channels
7.4.2 Crizotinib Capsules Distributors
7.5 Crizotinib Capsules Customer Analysis
8 Crizotinib Capsules Market Dynamics
8.1 Crizotinib Capsules Industry Trends
8.2 Crizotinib Capsules Market Drivers
8.3 Crizotinib Capsules Market Challenges
8.4 Crizotinib Capsules Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Crizotinib Capsules Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Crizotinib Capsules Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Crizotinib Capsules Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Crizotinib Capsules Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Crizotinib Capsules Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Crizotinib Capsules Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Crizotinib Capsules Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Crizotinib Capsules Average Price (US$/Ton) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Crizotinib Capsules, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Crizotinib Capsules, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Crizotinib Capsules, Product Types and Applications
 Table 12. Global Key Manufacturers of Crizotinib Capsules, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Crizotinib Capsules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Crizotinib Capsules Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Crizotinib Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Crizotinib Capsules Sales by Region (Tons), 2021–2026
 Table 18. Global Crizotinib Capsules Sales Market Share by Region (2021–2026)
 Table 19. Global Crizotinib Capsules Sales by Region (Tons), 2027–2032
 Table 20. Global Crizotinib Capsules Sales Market Share by Region (2027–2032)
 Table 21. Global Crizotinib Capsules Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Crizotinib Capsules Revenue Market Share by Region (2021–2026)
 Table 23. Global Crizotinib Capsules Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Crizotinib Capsules Revenue Market Share by Region (2027–2032)
 Table 25. North America Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Crizotinib Capsules Sales by Country (Tons), 2021–2026
 Table 27. North America Crizotinib Capsules Sales by Country (Tons), 2027–2032
 Table 28. North America Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Crizotinib Capsules Sales by Country (Tons), 2021–2026
 Table 32. Europe Crizotinib Capsules Sales by Country (Tons), 2027–2032
 Table 33. Europe Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Crizotinib Capsules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Crizotinib Capsules Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Crizotinib Capsules Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Crizotinib Capsules Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Crizotinib Capsules Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Crizotinib Capsules Sales by Country (Tons), 2021–2026
 Table 42. Latin America Crizotinib Capsules Sales by Country (Tons), 2027–2032
 Table 43. Latin America Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Crizotinib Capsules Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Crizotinib Capsules Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Crizotinib Capsules Sales (Tons) by Type (2021–2026)
 Table 51. Global Crizotinib Capsules Sales (Tons) by Type (2027–2032)
 Table 52. Global Crizotinib Capsules Sales Market Share by Type (2021–2026)
 Table 53. Global Crizotinib Capsules Sales Market Share by Type (2027–2032)
 Table 54. Global Crizotinib Capsules Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Crizotinib Capsules Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Crizotinib Capsules Revenue Market Share by Type (2021–2026)
 Table 57. Global Crizotinib Capsules Revenue Market Share by Type (2027–2032)
 Table 58. Global Crizotinib Capsules Price (US$/Ton) by Type (2021–2026)
 Table 59. Global Crizotinib Capsules Price (US$/Ton) by Type (2027–2032)
 Table 60. Global Crizotinib Capsules Sales (Tons) by Application (2021–2026)
 Table 61. Global Crizotinib Capsules Sales (Tons) by Application (2027–2032)
 Table 62. Global Crizotinib Capsules Sales Market Share by Application (2021–2026)
 Table 63. Global Crizotinib Capsules Sales Market Share by Application (2027–2032)
 Table 64. Global Crizotinib Capsules Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Crizotinib Capsules Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Crizotinib Capsules Revenue Market Share by Application (2021–2026)
 Table 67. Global Crizotinib Capsules Revenue Market Share by Application (2027–2032)
 Table 68. Global Crizotinib Capsules Price (US$/Ton) by Application (2021–2026)
 Table 69. Global Crizotinib Capsules Price (US$/Ton) by Application (2027–2032)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 73. Pfizer Crizotinib Capsules Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Qilu Pharmaceutical Company Information
 Table 76. Qilu Pharmaceutical Description and Business Overview
 Table 77. Qilu Pharmaceutical Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 78. Qilu Pharmaceutical Crizotinib Capsules Product
 Table 79. Qilu Pharmaceutical Recent Developments/Updates
 Table 80. Jiangsu Hengrui Medicine Company Information
 Table 81. Jiangsu Hengrui Medicine Description and Business Overview
 Table 82. Jiangsu Hengrui Medicine Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 83. Jiangsu Hengrui Medicine Crizotinib Capsules Product
 Table 84. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 85. Chia Tai Tianqing Pharmaceutical Group Company Information
 Table 86. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
 Table 87. Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 88. Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product
 Table 89. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
 Table 90. Cipla Limited Company Information
 Table 91. Cipla Limited Description and Business Overview
 Table 92. Cipla Limited Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 93. Cipla Limited Crizotinib Capsules Product
 Table 94. Cipla Limited Recent Developments/Updates
 Table 95. Glenmark Pharmaceuticals Company Information
 Table 96. Glenmark Pharmaceuticals Description and Business Overview
 Table 97. Glenmark Pharmaceuticals Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 98. Glenmark Pharmaceuticals Crizotinib Capsules Product
 Table 99. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 100. Natco Pharma Company Information
 Table 101. Natco Pharma Description and Business Overview
 Table 102. Natco Pharma Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 103. Natco Pharma Crizotinib Capsules Product
 Table 104. Natco Pharma Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Crizotinib Capsules Distributors List
 Table 108. Crizotinib Capsules Customers List
 Table 109. Crizotinib Capsules Market Trends
 Table 110. Crizotinib Capsules Market Drivers
 Table 111. Crizotinib Capsules Market Challenges
 Table 112. Crizotinib Capsules Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Crizotinib Capsules
 Figure 2. Global Crizotinib Capsules Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Crizotinib Capsules Market Share by Type: 2025 & 2032
 Figure 4. 200mg Product Picture
 Figure 5. 250mg Product Picture
 Figure 6. Global Crizotinib Capsules Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Crizotinib Capsules Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Crizotinib Capsules Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Crizotinib Capsules Market Size (US$ Million), 2021–2032
 Figure 13. Global Crizotinib Capsules Sales (Tons), 2021–2032
 Figure 14. Global Crizotinib Capsules Average Price (US$/Ton), 2021–2032
 Figure 15. Crizotinib Capsules Report Years Considered
 Figure 16. Crizotinib Capsules Sales Share by Manufacturers in 2025
 Figure 17. Global Crizotinib Capsules Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Crizotinib Capsules Players: Market Share by Revenue in Crizotinib Capsules in 2025
 Figure 19. Crizotinib Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Crizotinib Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Crizotinib Capsules Sales Market Share by Country (2021–2032)
 Figure 22. North America Crizotinib Capsules Revenue Market Share by Country (2021–2032)
 Figure 23. United States Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Crizotinib Capsules Sales Market Share by Country (2021–2032)
 Figure 26. Europe Crizotinib Capsules Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Crizotinib Capsules Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Crizotinib Capsules Revenue Market Share by Region (2021–2032)
 Figure 34. China Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Crizotinib Capsules Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Crizotinib Capsules Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Crizotinib Capsules Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Crizotinib Capsules Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Crizotinib Capsules by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Crizotinib Capsules by Type (2021–2032)
 Figure 54. Global Crizotinib Capsules Price (US$/Ton) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Crizotinib Capsules by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Crizotinib Capsules by Application (2021–2032)
 Figure 57. Global Crizotinib Capsules Price (US$/Ton) by Application (2021–2032)
 Figure 58. Crizotinib Capsules Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network